Yabao Pharmaceutical Group Co. Ltd. logo

Yabao Pharmaceutical Group Co. Ltd. (600351)

Market Closed
16 Oct, 06:57 AM
SSE SSE
¥
6. 84
-0.05
-0.7257%
¥
4.32B Market Cap
- P/E Ratio
0.6% Div Yield
34.28M Volume
- Eps
¥ 6.89
Previous Close
Add Transaction
Day Range
6.75 7.13
Year Range
5.6 7.45
Want to track 600351 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Yabao Pharmaceutical Group Co. Ltd. (600351) Statistics

Valuation metrics

Market Cap 4.32B
Enterprise value 4.01B
Trailing P/E (ttm) 15.43
Forward P/E -
PEG ratio 0.39
Price/Sales (ttm) 2.18
Price/Book (mrq) 1.73
Enterprise Value/Revenue 1.78
Enterprise Value/EBITDA 8.41

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 26.64M
Average volume (90 days) 24.14M

Price summary

52-Week low 5.6
52-Week high 7.45
Beta -
50-Day moving average 6.84
200-Day moving average 6.58

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.55
Trailing annual dividend yield 0.0778%
5-Year annual dividend yield -
Payout ratio 0.75
Dividend Date 1 Sep 2026
Ex-Dividend Date 1 Sep 2026
Last split factor 2:1
Last split Date 28 May 2010

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.14%
Operating margin 0.13%

Operational effectiveness

Return on assets 0.1%
Return on equity 0.11%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 3.24
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.47
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.33
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.81%
Book value per share (mrq) 3.99

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -